Agathe Ceppe

Agathe Ceppe

Auto-generated profile, based on publicly available information

Agathe Ceppe

The University of North Carolina at Chapel Hill School of Medicine, 130 Mason Farm Road, Campus Box 7020, Chapel Hill, NC 27599, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2023 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
KDKatherine Alexandra Despotes
Katherine Alexandra Despotes
ACAgathe S. Ceppe
Agathe S. Ceppe
SDScott H. Donaldson
Scott H. Donaldson

22 April 2021 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
WBWilliam D. Bennett
William D. Bennett
ABAllison Burbank
Allison Burbank
MAMartha Almond
Martha Almond
Jihong WuJihong Wu
Jihong Wu
ACAgathe Ceppe
Agathe Ceppe
DPDavid B. Peden
David B. Peden
Background: Impaired mucus clearance and airway mucus plugging have been shown to occur in moderate–severe asthma, especially during acute exacerbations. In cystic fibrosis, where airway mucus is dehydrated, it has been shown that inhaled hypertonic saline (HS) produces both acute and sustained enhancement of mucociliary clearance (MCC). The current study was designed to assess the acute and sustained effect of inhaled 7% HS on MCC in adult asthma.Methods: Well-controlled, moderate–severe female asthmatic patients (n=8) were screened with a single test dose of albuterol (four puffs by metered-dose inhaler) followed by HS (7% sodium chloride, 4 mL using PARI LC Star nebuliser). Spirometry was measured pre-treatment and 5 and 30 min post-treatment for safety. MCC was measured using γ-scintigraphy on three separate visits: at baseline, during inhalation and 4 h after a single dose of HS.Results: MCC was acutely enhanced during HS treatment; mean±sdclearance over 60 min of dynamic imaging (Ave60Clr) was 8.9±7.9% (baseline)versus23.4±7.6% (acute HS) (p<0.005). However, this enhancement was not maintained over a 4-h period where post-HS treatment Ave60Clr was 9.3±8.2%. In this small cohort we found no decrements in lung function up to 30 min post-treatment (forced expiratory volume in 1 s 97.4±10.0% predicted pre-treatment and 98.9±10.7% predicted 30 min post-treatment).Conclusion: While MCC was rapidly enhanced during 7% HS treatment there was no effect on MCC at 4 h post-treatment. While these findings may not support aerosolised HS use for maintenance therapy, they do suggest a benefit of treating acute exacerbations in patients with moderate–severe asthma.

20 May 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ATAaron Trimble
Aaron Trimble
KZKirby Zeman
Kirby Zeman
Jihong WuJihong Wu
Jihong Wu
ACAgathe Ceppe
Agathe Ceppe
WBWilliam Bennett
William Bennett
SDScott Donaldson
Scott Donaldson
Background: Cystic fibrosis (CF) is an inherited disorder causing impaired mucociliary clearance within the respiratory tract, and is associated with bronchiectasis, chronic respiratory infections, and early death. Airway clearance therapies have long been a cornerstone of management of individuals with CF, although evidence supporting their use is lacking. We designed a randomized controlled trial to quantitatively compare the effects of different forms of airway clearance on mucociliary clearance.Methods: Three different physiotherapy methods to augment cough-clearance were studied in addition to cough-clearance alone: high-frequency chest-wall oscillating vest, oscillatory positive expiratory pressure, and whole-body vibration. We used gamma scintigraphy after inhalation of radiolabeled particles to quantify mucus clearance before, during, and after physiotherapy. As secondary endpoints, we measured concentrations of small molecules in exhaled breath that may impact mucus clearance.Results: Ten subjects were enrolled and completed study procedures. No differences were identified between any method of airway clearance, including cough clearance alone. We did identify changes in certain small molecule concentrations in exhaled breath following airway clearance.Conclusions: Due to the limitations of this study, we do not believe the negative results suggest a change in clinical practice with regard to airway clearance. Findings pertaining to small molecules in exhaled breath may serve as future opportunities for study.

3 May 2021
Verified
Conference Paper
Open access
RIRoy A. Pleasants II
Roy A. Pleasants II
ACA. Ceppe
A. Ceppe
AHA.G. Henderson
A.G. Henderson
ASA. Shaikh
A. Shaikh
VBV. Bayer
V. Bayer
MDM.B. Drummond
M.B. Drummond